(Q43198008)

15 November 2017

title

[Testosterone and the metabolic syndrome]. (English)

1 reference

15 November 2017

1 reference

M Schubert

1

1 reference

15 November 2017

F Jockenhövel

series ordinal

2

1 reference

15 November 2017

language of work or name

German

0 references

publication date

1 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

49

1 reference

15 November 2017

issue

1

1 reference

15 November 2017

page(s)

47-50

1 reference

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

15 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00120-009-2198-7

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

12 December 2020

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

1 reference

12 December 2020

Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men.

1 reference

12 December 2020

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

12 December 2020

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

12 December 2020

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

1 reference

12 December 2020

Testosterone dose-response relationships in healthy young men.

1 reference

12 December 2020

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

1 reference

12 December 2020

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

1 reference

12 December 2020

The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics.

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

1 reference

12 December 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

12 December 2020

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

1 reference

12 December 2020

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

12 December 2020

Comment on the provisional report from the WHO consultation

1 reference

12 December 2020

[Metabolic syndrome -- myths, mechanisms, management]

1 reference

12 December 2020

10.1007/S00120-009-2198-7

Identifiers

DOI

1 reference

15 November 2017

1 reference